Here are stocks to watch out for:
Reliance Industries: The oil-to-telecom major Reliance Industries announced consolidated profit at Rs 13,656 crore in Q2FY23, against Rs 13,680 crore in the same period last year. Revenues surged 33.7% to Rs 2.32 lakh crore, led by strong performance of the oil-to-chemical, telecom and retail operations during the quarter. Consolidated operating profit, including the impact of special additional excise duty imposed by the government in July, surged 14.5% on year to Rs 34,663 crore. Jio Platforms recorded 27% YoY growth in profit at Rs 4,729 crore backed by strong topline and operating performance, with average revenue per user growing 23.5% YoY to Rs 177.2 per subscriber per month during the quarter.
ICICI Bank: The country's second largest private sector lender witnessed 37% YoY growth in Q2FY23 standalone profit at Rs 7,558 crore, with a significant fall in bad loan provisions. Net interest income increased 26.5% YoY to Rs 14,787 crore, with net interest margin expanding around 30 bps on sequential as well as on year basis.
Kotak Mahindra Bank: The bank reported 27% YoY growth in standalone profit at Rs 2,581 crore for Q2FY23. Net interest income also grew 27% YoY to Rs 5,099 crore, with net interest margin expanding by 72 bps YoY to 5.17% for the quarter. The bank reported a significant 68% YoY decline in provisions and contingencies at Rs 137 crore, while the asset quality performance for the quarter has also seen further improvement in Q2.
RBL Bank: The bank's Q2FY23 profit grew 6.5 times YoY to Rs 201.55 crore on a low base. There was a considerable decline in provisions and contingencies at Rs 241 crore, a YoY drop of 26 percent. Net interest income grew 16% YoY to Rs 1,064 crore during the quarter, with net interest margin rising 49 bps YoY to 4.55%. Gross NPA declined by 28 bps QoQ but there was a 10 bps QoQ increase in net NPA.
Yes Bank: The lender recorded a 32% YoY decline in profit at Rs 153 crore, impacted by higher provisions for bad loans that surged 54% YoY to Rs 583 crore in Q2FY23. Net interest income for the quarter at Rs 1,991 crore increased by 32% YoY, with net interest margin expanding by 40 bps YoY (up 20 bps QoQ) to 2.6%.
Hindustan Unilever: The company's profit grew by 19.6% year-on-year to Rs 2,616 crore in quarter ended September FY23, with domestic volume growth at 4%. Revenue increased 15.9% YoY to Rs 14,751 crore during the quarter. EBITDA rose by 7.8% to Rs 3,377 crore, but margin fell by 170 bps YoY to 22.9% in Q2FY23. HUL declared an interim dividend of Rs 17 per share for FY23.
Zydus Lifesciences: The company has received approval from USFDA to market Ketorolac tromethamine tablets. The drug is used for relieving moderately severe pain, usually after surgery. The drug will be manufactured at company's formulation manufacturing facility at Ahmedabad SEZ.
Magazine : 
.jpg "December Spotlight")
